Lupin gets US nod to sell copy of oral contraceptive Lutera

Moneycontrol Bureau

Pharma major Lupin has received US Food and Drug Administration approval to sell a generic version of Watson Laboratories' Lutera 28 Tablets.

The Levonorgestrel and Ethinyl Estradiol Tablets in 0.1mg / 0.02mg tablets are a combined oral contraceptive indicated for the prevention of pregnancy in women who choose oral contraceptive as a method of contraception, Lupin said on Tuesday.

It will be marketing its generic product shortly, the company said.

Lutera tablets had annual US sales of about USD 103.6 million, according to IMS Health data for Sept 2012.

Lupin shares were down 0.7 percent at Rs 590.50 on NSE in morning trade.